Our Science

World First
Discovery.

Created By Nature,
Confirmed By Science.
PATENTED in 30+ countries
30+ YEARS of scientific studies
WORLD first discovery
content science 03

Medical researchers and scientists have for many years been researching ways in which to synthetically increase the IGF-1 hormone  (insulin-like growth factor 1) .

The IGF-1 hormone is responsible for promoting the growth of new cells and capillaries. This is especially important as the body ages. The IGF-1 cannot be directly or artificially increased by supplementation.

Then our Chief Scientist, Dr Jian Guan made a world first discovery. She discovered that a molecule called cGP (cyclic Glycine-Proline) was responsible for controlling the IGF-1 hormone in our body. Thus by increasing the level of cGP in our body, the cGP will essentially command the IGF-I to build more blood vessels.

Dr Jian Guan, was then recognised as the world-wide authority on cGP. In 2017 she discovered that NZ blackcurrants contained high volumes of natural cGP which when taken would regulate optimum levels of IGF-1 in the body. 

cGPMAX web 1200x800px science

Dr Jian’s clinical scientific research studies validated the levels of cGP the human body needs. Trials were then undertaken to establish how our product cGPMAX™ could deliver enough natural cGP to the body to lift and maintain IGF-1 levels in the human body. 

The culmination of the research has led The cGP Lab to develop our hero ingredient called cGPMAX™.

The cGP Lab has developed products that confidently and consistently deliver the recommended daily dose of natural cGP from New Zealand blackcurrants.

The cGP Lab are now utilising this knowledge to further research the testing and commercialisation of other sources of natural cGP and the effects of supplementation of cGPMAX™ on various health conditions, including metabolic syndromes.

The Impact of cGP on Neurological Conditions

Memory Loss Caused by Poor Circulation in Ageing Brains
Brain Degeneration in Parkinson’s Disease
Alzheimer’s Disease
Ischemic Attack, Commonly Known as a Stroke
Metabolic Disorders
Scientific Papers Referenced Above